130 related articles for article (PubMed ID: 26060929)
1. Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interaction.
Goldman SM; Umbach DM; Kamel F; Tanner CM
Eur J Neurol; 2015 Jul; 22(7):e75. PubMed ID: 26060929
[No Abstract] [Full Text] [Related]
2. Head injury, α-synuclein Rep1, and Parkinson's disease.
Goldman SM; Kamel F; Ross GW; Jewell SA; Bhudhikanok GS; Umbach D; Marras C; Hauser RA; Jankovic J; Factor SA; Bressman S; Lyons KE; Meng C; Korell M; Roucoux DF; Hoppin JA; Sandler DP; Langston JW; Tanner CM
Ann Neurol; 2012 Jan; 71(1):40-8. PubMed ID: 22275250
[TBL] [Abstract][Full Text] [Related]
3. Head injury, α-synuclein genetic variability and Parkinson's disease.
Lee PC; Bordelon Y; Bronstein J; Sinsheimer JS; Farrer M; Ritz B
Eur J Neurol; 2015 May; 22(5):874-8. PubMed ID: 25370538
[TBL] [Abstract][Full Text] [Related]
4. Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.
Huang Y; Rowe DB; Halliday GM
J Parkinsons Dis; 2011; 1(3):271-6. PubMed ID: 23939307
[TBL] [Abstract][Full Text] [Related]
5. Head injury, potential interaction with genes, and risk for Parkinson's disease.
Gao J; Liu R; Zhao E; Huang X; Nalls MA; Singleton AB; Chen H
Parkinsonism Relat Disord; 2015 Mar; 21(3):292-6. PubMed ID: 25603768
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein repeat variants and survival in Parkinson's disease.
Chung SJ; Biernacka JM; Armasu SM; Anderson K; Frigerio R; Aasly JO; Annesi G; Bentivoglio AR; Brighina L; Chartier-Harlin MC; Goldwurm S; Hadjigeorgiou G; Jasinska-Myga B; Jeon BS; Kim YJ; Krüger R; Lesage S; Markopoulou K; Mellick G; Morrison KE; Puschmann A; Tan EK; Crosiers D; Theuns J; Van Broeckhoven C; Wirdefeldt K; Wszolek ZK; Elbaz A; Maraganore DM;
Mov Disord; 2014 Jul; 29(8):1053-7. PubMed ID: 24578302
[TBL] [Abstract][Full Text] [Related]
7. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
Pavlou MAS; Pinho R; Paiva I; Outeiro TF
Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
[TBL] [Abstract][Full Text] [Related]
8. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.
Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A
Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025
[TBL] [Abstract][Full Text] [Related]
9. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
[TBL] [Abstract][Full Text] [Related]
10. SNCA Rep1 promoter variability influences cognition in Parkinson's disease.
Ng ASL; Tan YJ; Zhao Y; Saffari SE; Lu Z; Ng EYL; Ng SYE; Chia NSY; Setiawan F; Xu Z; Tay KY; Au WL; Tan LCS; Tan EK
Mov Disord; 2019 Aug; 34(8):1232-1236. PubMed ID: 31234238
[TBL] [Abstract][Full Text] [Related]
11. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.
Ross OA; Gosal D; Stone JT; Lincoln SJ; Heckman MG; Irvine GB; Johnston JA; Gibson JM; Farrer MJ; Lynch T
Mech Ageing Dev; 2007; 128(5-6):378-82. PubMed ID: 17531291
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.
Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A
Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971
[TBL] [Abstract][Full Text] [Related]
13. Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.
Bjørnarå KA; Pihlstrøm L; Dietrichs E; Toft M
BMC Neurol; 2018 Feb; 18(1):20. PubMed ID: 29466944
[TBL] [Abstract][Full Text] [Related]
14. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
Maraganore DM; de Andrade M; Elbaz A; Farrer MJ; Ioannidis JP; Krüger R; Rocca WA; Schneider NK; Lesnick TG; Lincoln SJ; Hulihan MM; Aasly JO; Ashizawa T; Chartier-Harlin MC; Checkoway H; Ferrarese C; Hadjigeorgiou G; Hattori N; Kawakami H; Lambert JC; Lynch T; Mellick GD; Papapetropoulos S; Parsian A; Quattrone A; Riess O; Tan EK; Van Broeckhoven C;
JAMA; 2006 Aug; 296(6):661-70. PubMed ID: 16896109
[TBL] [Abstract][Full Text] [Related]
15. Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease.
Gruschus JM
PLoS One; 2015; 10(7):e0133863. PubMed ID: 26214314
[TBL] [Abstract][Full Text] [Related]
16. Expression of alpha-synuclein mRNA in Parkinson's disease.
Papapetropoulos S; Adi N; Mash DC; Shehadeh L; Bishopric N; Shehadeh L
Mov Disord; 2007 May; 22(7):1057-9; author reply 1057. PubMed ID: 17373725
[No Abstract] [Full Text] [Related]
17. Parkinson disease: α-synuclein mutational screening and new clinical insight into the p.E46K mutation.
Pimentel MM; Rodrigues FC; Leite MA; Campos Júnior M; Rosso AL; Nicaretta DH; Pereira JS; Silva DJ; Della Coletta MV; Vasconcellos LF; Abreu GM; Dos Santos JM; Santos-Rebouças CB
Parkinsonism Relat Disord; 2015 Jun; 21(6):586-9. PubMed ID: 25817515
[TBL] [Abstract][Full Text] [Related]
18. Genetics of Parkinson's disease: alpha-synuclein and other insights from Greece.
Proukakis C
Eur J Neurol; 2014 Jul; 21(7):946-7. PubMed ID: 24460978
[No Abstract] [Full Text] [Related]
19. Alpha-synuclein-based models of Parkinson's disease.
Dehay B; Fernagut PO
Rev Neurol (Paris); 2016; 172(6-7):371-8. PubMed ID: 27158042
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
Berg D; Niwar M; Maass S; Zimprich A; Möller JC; Wuellner U; Schmitz-Hübsch T; Klein C; Tan EK; Schöls L; Marsh L; Dawson TM; Janetzky B; Müller T; Woitalla D; Kostic V; Pramstaller PP; Oertel WH; Bauer P; Krueger R; Gasser T; Riess O
Mov Disord; 2005 Sep; 20(9):1191-4. PubMed ID: 15895422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
